Top Page
Elevate Uranium Ltd
(Sydney:EL8)
Elevate Uranium Ltd (EL8) vs. iShares MSCI Australia ETF (EWA)
Elevate Uranium Ltd Business Overview & Revenue Model
Elevate Uranium Ltd Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 768.50K | 768.50K | 182.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 945.72K | 768.50K | -121.67K | -117.68K | -85.52K | -54.29K |
| EBITDA | -4.31M | -11.85M | -10.62M | -8.51M | -5.68M | -2.66M |
| Net Income | -4.75M | -12.32M | -10.75M | -8.63M | -5.73M | -2.60M |
Balance Sheet | ||||||
| Total Assets | 25.46M | 25.46M | 13.26M | 12.54M | 19.33M | 9.96M |
| Cash, Cash Equivalents and Short-Term Investments | 21.71M | 21.71M | 10.83M | 10.06M | 15.81M | 6.66M |
| Total Debt | 432.41K | 432.41K | 74.21K | 146.03K | 177.27K | 99.29K |
| Total Liabilities | 1.57M | 1.57M | 1.48M | 1.02M | 838.59K | 429.54K |
| Stockholders Equity | 23.89M | 23.89M | 11.78M | 11.52M | 18.49M | 9.53M |
Cash Flow | ||||||
| Free Cash Flow | -8.05M | -11.71M | -9.31M | -5.90M | -4.49M | -2.40M |
| Operating Cash Flow | -8.01M | -11.62M | -9.24M | -5.83M | -4.38M | -2.33M |
| Investing Cash Flow | -425.62K | -714.24K | -73.79K | -74.52K | -137.62K | -61.28K |
| Financing Cash Flow | -104.30K | 23.22M | 10.09M | 158.86K | 13.67M | 7.99M |
Elevate Uranium Ltd Technical Analysis
Elevate Uranium Ltd Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
57 Neutral | AU$254.10M | ― | -6.30% | ― | ― | -67.12% | |
47 Neutral | AU$19.29M | -41.82 | -0.93% | ― | ― | 8.33% | |
47 Neutral | $228.27M | ― | -7.01% | ― | -100.00% | 49.49% | |
43 Neutral | AU$9.33M | -4.48 | -75.69% | ― | ― | -141.67% | |
41 Neutral | £197.53M | -12.15 | -26.26% | ― | ― | -75.25% | |
38 Underperform | AU$123.40M | -8.94 | -69.11% | ― | ― | 1.38% |
Elevate Uranium Ltd Corporate Events
Elevate Uranium Ltd has successfully raised $25 million through a placement of shares, significantly strengthening its financial position. This funding will be used to accelerate the U-pgrade™ pilot plant program and expand resource drilling in Namibia and Australia, supporting the company’s strategy to enhance its uranium portfolio and pursue strategic growth opportunities.
The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.
Elevate Uranium Ltd has requested a trading halt on its securities pending a significant announcement related to a capital raising initiative. This move is intended to provide the company with additional resources to enhance its market position and operational capabilities, with trading expected to resume by 3 November 2025.
The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.
Elevate Uranium Ltd has announced a proposed issue of securities, including service options and performance rights, scheduled for November 28, 2025. This move is part of the company’s strategic efforts to enhance its financial position and support its ongoing projects, potentially strengthening its market presence and offering benefits to stakeholders.
The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.
Elevate Uranium Ltd has announced its 2025 Annual General Meeting of Shareholders scheduled for 27 November 2025. The meeting will be held in West Perth, and shareholders are encouraged to submit their proxy voting instructions online by 25 November 2025. The company will not be sending physical copies of the meeting notice, which can be accessed online. This move reflects a shift towards digital communication, potentially enhancing shareholder engagement and operational efficiency.
The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.
Elevate Uranium Ltd has announced its Annual General Meeting, which will take place on November 27, 2025, at CWA House in West Perth. Shareholders are encouraged to participate in the meeting, either in person or by proxy, to ensure their votes are counted. The company has opted not to send hard copies of the meeting notice, directing shareholders to access it online, reflecting a shift towards digital communication.
The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.
Elevate Uranium Ltd announced the issuance of unquoted equity securities, including LTI Performance Rights, LTI Options, and STI Performance Rights, as part of an employee incentive scheme. This move is aimed at aligning employee interests with company goals and potentially enhancing operational performance, which could strengthen its position in the uranium market.
The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.
Elevate Uranium Ltd has announced the grant of unlisted securities under its 2023 Employee Incentive Plan. This includes LTI Performance Rights, LTI Options, and STI Performance Rights, all with specific vesting conditions and expiry dates. This move is aimed at incentivizing employees and aligning their interests with the company’s long-term goals, potentially impacting the company’s operational efficiency and market positioning.
The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.
Elevate Uranium Ltd has entered into an agreement to sell its Oobagooma Uranium Project in Western Australia to Orpheus Uranium Ltd. This divestment aligns with Elevate’s strategic focus on its core projects, potentially strengthening its position in the uranium market by allowing it to concentrate resources on its key initiatives. The transaction involves cash and equity payments, with Elevate becoming a significant shareholder in Orpheus, indicating a supportive relationship moving forward.
The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.
Orpheus Uranium Limited, a company focused on consolidating underexplored uranium assets, has announced its acquisition of the Oobagooma Uranium Project from Elevate Uranium Ltd’s subsidiary. Located in Western Australia’s Canning Basin, the project is notable for its sedimentary-style roll-front mineralization and historical evidence of significant uranium deposits. This acquisition aligns with Orpheus’ strategy to enhance its portfolio of uranium assets across various development stages, leveraging modern exploration techniques to unlock value from known targets.
The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.
Cumulus Wealth Pty Ltd has ceased to be a substantial holder in Elevate Uranium Ltd as of September 30, 2025. This change in substantial holding could impact Elevate Uranium’s shareholder dynamics and influence within the company, potentially affecting its strategic decisions and market positioning.
The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.
Elevate Uranium Ltd has announced the date for its 2025 Annual General Meeting, scheduled for November 27, 2025, in West Perth. A key agenda item will be the election of directors, with nominations closing on October 7, 2025. This meeting is significant for stakeholders as it will influence the company’s leadership and strategic direction.
Elevate Uranium Ltd has released its corporate governance statement, which adheres to the ASX Corporate Governance Council’s principles and recommendations. The statement outlines the company’s commitment to maintaining robust governance practices, including board oversight and management responsibilities. This announcement reinforces Elevate Uranium’s dedication to transparency and accountability, potentially strengthening its position in the market and providing assurance to stakeholders about its governance standards.
Elevate Uranium Ltd has released its Corporate Governance Statement for the financial year ending June 30, 2025. The statement outlines the company’s adherence to the ASX Corporate Governance Council’s recommendations, detailing the roles and responsibilities of the Board, Chair, and management. The company has implemented a Corporate Governance Plan, which is accessible on their website, to guide their governance duties. This release highlights Elevate Uranium’s commitment to transparency and structured governance, which may enhance stakeholder confidence and potentially improve its industry positioning.
Elevate Uranium Limited announced a significant change in the interests of its director, Scott Perry, who has acquired 990,280 fully paid ordinary shares through an on-market trade. This acquisition, valued at $0.2537 per share, reflects a strategic move that could strengthen Perry’s influence within the company and potentially impact its governance and decision-making processes.